For in vivo studies, ID8-F3 murine ovarian cancer cells expressing mouse IL6/1 (mIL6/1) were administered intraperitoneally (I.P.)as a cell-based therapy to C57BL/6 female mice bearing established ID8-F3 luciferase tumors. Here, IL6 is linked to ovarian cancer.